FBTTX Mutual Fund

FBTTX Mutual Fund (Fidelity Advisor Biotechnology Fund Class M) is managed by Fidelity Investments (US) with $156.2M in net assets. FBTTX expense ratio is 1.21%, holding 92 positions across sectors including Health Care, Financials. Inception date: 2000-12-27.

FBTTX performance shows a YTD return of 21.37%. The 1-year return is 62.26% and the 5-year return is 12.33%. FBTTX dividend yield stands at 1.03%, paid semi-annually.

FBTTX top holdings include Abbvie Inc. (16.6%), Gilead Sciences (6.6%), Alnylam Pharmaceuticals Inc. (5.0%), Ascendis Pharma A/S (4.5%), Cogent Biosciences Inc (3.8%). Go to all FBTTX holdings, FBTTX sectors, or FBTTX dividends.

FBTTX can be compared against other funds. Use FBTTX overlap to find shared positions, or FBTTX vs another fund for a side-by-side view. FBTTX alternatives are available via the screener, along with tax-loss harvesting opportunities.